Clinical Trial Update: Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial results for botulinum toxin type A in idiopathic overactive bladder with urinary incontinence have been completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2013-03-05